Novo Nordisk Strikes US Medicare Price Deal
Favicon 
www.newsmax.com

Novo Nordisk Strikes US Medicare Price Deal

Novo Nordisk said Wednesday it had agreed to a lower price under the U.S. Medicare scheme for semaglutide, the active ingredient in its key drugs Ozempic and Wegovy, in a deal that some analysts said sounded less onerous than feared.